Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
inhibitor for protein type-1 phosphatase (PP1) and myosin light-chain phosphatase (MLCP)\\\\; substrate of protein kinase C (PKC) [RGD, Feb 2006].. Additionally we are shipping Protein Phosphatase 1, Regulatory (Inhibitor) Subunit 14B Antibodies (14) and Protein Phosphatase 1, Regulatory (Inhibitor) Subunit 14B Proteins (7) and many more products for this protein.
Showing 4 out of 9 products:
Whereas CPI-17 staining was diffuse, PHI-1 was concentrated along the cell membrane in distinct foci. The common tissue distribution but different cellular localization of PHI-1 and CPI-17 suggest distinctive physiological roles for these PP1 inhibitors.
PHI-1 participates in regulatory events at the trailing edge of migrating cells and modulates retraction of endothelial and epithelial cells
An inhibitory phosphoprotein that inhibits the myosin- and glycogen-associated holoenzyme versions of protein type-1 phosphatase (PP1) as well as the monomeric catalytic subunit of PP1 in multiple tissues.
results indicate that phosphorylation of I-1 at Ser67 and Thr75 is associated with increased PP1 activity and depressed cardiomyocyte Ca(2 (show CA2 ELISA Kits)+)-cycling, which manifests in geometrical alterations over the long term
inhibitor for protein type-1 phosphatase (PP1) and myosin light-chain phosphatase (MLCP)\; substrate of protein kinase C (PKC)
phospholipase C beta-3 neighboring gene protein
, phospholipase C-beta-3 neighbouring gene protein
, protein phosphatase 1 regulatory subunit 14B
, phosphatase holoenzyme inhibitor 1
, phospholipase c neighboring
, protein phosphatase 1, regulatory (inhibitor) 5 subunit 14B
, ubiquitous PKC-potentiated PP1 inhibitor